Jayne Jacova Feld, MA

With the FDA approval of Zepbound (tirzepatide) for obstructive sleep apnea, GLP-1 receptor agonists harbor potential beyond weight and diabetes management.

Dr Umakanth Katwa and Dr Rafael Pelayo give clinical guidance on the accurate diagnosis and evidence-based treatment of pediatric insomnia.